Health & Personal Care
HIGH
FDA DRUG
Eptifibatide Injection Recalled Over Labeling Error
Slate Run Pharmaceuticals recalled Eptifibatide Injection on February 12, 2026. The recall affects all lots of the 75 mg/100 mL vial due to incorrect dosing information. Healthcare providers and consumers must stop using the product immediately.
EPTIFIBATIDE
Labeling: Not